DESMOPRESSIN News
DESMOPRESSIN currently has 0 news articles, with 16 predicted indications.
This page combines the AI-predicted indications for DESMOPRESSIN with the latest health news. Indications highlighted in orange have recent news coverage.
Drug Information
- Evidence level: L5
- Predicted indications (16):
- nocturnal enuresis (99.0%)
- hereditary von Willebrand disease (99.0%)
- symptomatic form of hemophilia in female carriers (99.0%)
- von Willebrand disease (hereditary or acquired) (99.0%)
- hemophilia (99.0%)
- von Willebrand disease (99.0%)
- congenital prothrombin deficiency (99.7%)
- inherited thrombophilia (99.4%)
- Glanzmann thrombasthenia (99.3%)
- primary release disorder of platelets (99.3%)
- pseudo-von Willebrand disease (99.2%)
- Scott syndrome (99.2%)
- flood factor deficiency (99.2%)
- thrombocytopenic purpura (99.0%)
- bleeding diathesis due to a collagen receptor defect (99.0%)
- hereditary thrombocytosis with transverse limb defect (99.0%)
Related News (0)
No related news yet. When news mentions this drug, it will be collected and shown here automatically.
Disclaimer: The news on this page is collected automatically and is for research reference only; it does not constitute medical advice.